title: Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism.
authors.affiliation: Evidera, London, UK.
authors.forename: T
authors.initials: T
authors.lastname: Lanitis
authors.affiliation: Bristol-Myers Squibb Company, Princeton, NJ, USA.
authors.forename: M
authors.initials: M
authors.lastname: Hamilton
authors.affiliation: Pfizer, Inc., New York, NY, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Rublee
authors.affiliation: Evidera, Bethesda, MD, USA.
authors.forename: R
authors.initials: R
authors.lastname: Leipold
authors.affiliation: Evidera, Bethesda, MD, USA.
authors.forename: P
authors.initials: P
authors.lastname: Quon
authors.affiliation: Evidera, London, UK.
authors.forename: C
authors.initials: C
authors.lastname: Browne
authors.affiliation: Guy's and St Thomas' NHS Foundation Trust, London, UK.
authors.forename: A T
authors.initials: AT
authors.lastname: Cohen